NAPPA
News & Events

Cross-border execution, on the record.

Partnerships, events, appointments, and organizational updates from NAPPA and our global chapters.

Appointment

NAPPA appoints Chen Feng as Shanghai Regional Head

Boren Capital's founder joins NAPPA to deepen the alliance's footprint in China's leading biopharma and capital hub.

Read more →
Appointment

NAPPA welcomes Dr. Hongwen Zhu as Scientific Advisor

A neuroscientist, chief physician, and digital-health builder joins NAPPA's scientific advisory bench.

Read more →
Appointment

NAPPA welcomes Dr. Joy Wang as Strategic Advisor

20+ years of portfolio strategy and Go/No-go decision experience across Novartis, Eli Lilly, Baxter, and Dendreon joins NAPPA's advisory bench.

Read more →
Appointment

NAPPA appoints Dr. Wu Zhou as Regional Head for Malaysia, Indonesia, and Vietnam

Pharmasolution Asia's founder joins NAPPA to drive strategic synergy between southern China and Southeast Asian life sciences.

Read more →
Appointment

NAPPA appoints Tiffany Tse as Head of Hong Kong Region

A capital-strategy and cross-border BD veteran joins NAPPA to anchor the alliance's Hong Kong presence and deepen U.S.–Asia biopharma synergy.

Read more →
Partnership

NAPPA and TONACEA join forces ahead of CPIC 2026

A strategic partnership ahead of the China Pharmaceutical Innovation and Competitiveness Conference (CPIC) 2026, formalizing a joint commitment to cross-border execution between U.S. and Chinese biopharma.

Read more →
Appointment

NAPPA appoints Yu Cao and Junfang Li as Scientific Advisors

Two scientific advisor appointments deepen NAPPA's bench across translational research and drug development.

Read more →
Org Update

NAPPA launches Australian Chapter

The first regional chapter outside North America, anchoring NAPPA's presence in the Asia-Pacific biopharma corridor.

Read more →
Appointment

NAPPA names initial advisory board across four pillars

The inaugural advisory board spans Science, Drug R&D, Industry Translation, and Capital — the four dimensions NAPPA considers essential for cross-border execution.

Read more →
Event

NAPPA founding team holds inaugural meeting in Boston

The seven-member founding team convened in Boston on March 21, 2026 to formally launch the alliance and ratify its dual-track non-profit and commercial structure.

Read more →
Partnership

NAPPA partners with Guangdong Medical Valley (MEDV)

A partnership designed to build a bi-directional bridge between Boston innovation and China's industrial transformation, anchored at one of China's leading biomedical industry platforms.

Read more →
Partnership

NAPPA and Tianjin International Cooperation Demonstration Zone form strategic partnership

A partnership focused on resource integration, deep participation, and results-oriented execution within the Tianjin International Cooperation Demonstration Zone for the Health Industry.

Read more →
Partnership

Strategic partnership with the Chinese Non-Government Medical Institutions Association

A pivotal partnership signaling NAPPA's transition from platform-building into substantive project advancement and industry coordination.

Read more →